Gilead Sciences (United States)
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19, including ledipasvir/sofosbuvir and sofosbuvir. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Gilead Sciences (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
53%
Total
Publications
5.6K
Total Open
Publications
3K
Total
Citations
258K
Open Access
Percentage
53%
Total
Publications
5.6K
Total Open
Publications
3K
Total
Citations
258K
Breakdown
Publisher Open
19%
Both
24%
Other Platform Open
9%
Closed
48%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 42%
978
Hybrid 23%
540
No Guarantees 35%
814
Other Platform Open
Domain 80%
1.5K
Institution 19%
365
Other Internet 14%
270
Public 3%
55
Preprint 1%
19
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 1.5K |
DOI | Other Internet | 272 |
Europe PMC | Domain | 61 |
Figshare | Public | 51 |
DANS - Data Archiving and Networked Services | Institution | 35 |
Le Centre pour la Communication Scientifique Directe - HAL - Diderot | Institution | 31 |
University of Modena and Reggio Emilia - IRIS UNIMORE | Institution | 25 |
Université Libre de Bruxelles - Dépôt institutionnel de l'Université libre de Bruxelles | Institution | 18 |
Universita Degli Studi Di Milano - Archivio Istituzionale della Ricerca | Institution | 17 |
U.S. Department of Energy Office of Scientific and Technical Information - OSTI OAI | Institution | 17 |